• Dr. Philip Kantoff Supports the Need For Personalized Medicine for Men with Advanced Prostate Cancer

    Updated: 2012-02-08 19:32:31
    At the 2012 Genitourinary Cancers Symposium ASCO conference, Dr. Philip Kantoff (Dana-Farber Cancer Institute, Harvard Medical School Boston, MA) suggested taking a personalized approach to the individualized treatment plan for all men suffering from advanced prostate cancer. Dr. Kantoff said, “Few patients with advanced prostate cancer are currently cured with ADT (but anecdotally, long-term survival [...]

  • FDA Panel Turns Down Bone Drug in Prostate Ca

    Updated: 2012-02-08 19:24:29
    WASHINGTON -- An FDA panel has voted 12-1 against expanding the indication for Amgen's denosumab (Xgeva) to prevent the spread of prostate cancer to the bones in men with a high-risk form of the disease.

  • US scientists show how immune system 'prunes' tumours

    Updated: 2012-02-08 18:08:00
    Laboratory research by US scientists has shown for the first time how the body's immune system shapes how a tumour grows.

  • Breast Cancer Drug May Weaken Bones Study Finds

    Updated: 2012-02-08 00:14:01
    , Health News Breast Cancer Drug May Weaken Bones , Study Finds Print E-mail TUESDAY , Feb . 7 HealthDay News A drug used to prevent breast cancer in women at high risk for the disease appears to cause bone loss in some postmenopausal women , a new study . finds The drug , Aromasin exemestane has been shown to reduce the odds of breast cancer by 65 percent , but it also worsens bone density by about three times in older women who are taking it , Canadian researchers . report The drug did affect bone density at the hip and spine , said lead researcher Dr . Angela Cheung , a senior scientist at the University Health Network in Toronto . It does not affect everyone about 65 percent of women have some bone loss . The fear of bone loss is not a reason not to take the drug , Cheung said . You

  • Risk of Death From Certain Breast Cancers May Rise With Age

    Updated: 2012-02-08 00:14:00
    Health News Risk of Death From Certain Breast Cancers May Rise With Age Print E-mail TUESDAY , Feb . 7 HealthDay News The risk of dying from a hormone receptor-positive breast cancer increases with age , according to new research . And one reason might be that older women with breast cancer are undertreated compared to their younger . peers For women between the ages of 65 and 74, the risk of dying from breast cancer was 25 percent higher than for women under 65. For those 75 and older , the risk of death was 63 percent higher than for women under 65, according to the new study . This study showed that among postmenopausal , non-metastatic , breast cancer patients , elderly patients have a higher risk of dying from breast cancer than younger patients , said study author Dr . Cornelis van

  • Will the FDA Approve Xgeva – It is “Up In The Air”

    Updated: 2012-02-07 18:56:24
    Prior to the formal review, the FDA has raised questions about the ultimate approval of Amgen’s Xgeva (denosumab) for men with metastatic, advanced prostate cancer who have not yet developed metastasized to the bone. Xgeva has been shown to delay tumors spreading to bones, but it does not extend life, the holy grail of the [...]

  • Certain Cancer Drugs May Have Fatal Side Effects Analysis

    Updated: 2012-02-07 16:13:28
    : Health News Certain Cancer Drugs May Have Fatal Side Effects : Analysis Print E-mail MONDAY , Feb . 6 HealthDay News Treatment with three relatively new cancer drugs may be linked to a slightly increased risk of death , a new analysis . suggests While the risk is low , it should be taken into account by doctors and patients , according to Dana-Farber Cancer Institute scientists and . colleagues The investigators analyzed the findings of 10 clinical trials that included nearly 4,700 patients treated with sorafenib Nexavar for kidney and liver cancer sunitinib Sutent for kidney cancer and gastrointestinal stromal tumor or pazopanib Votrient for kidney . cancer These so-called targeted drugs are used to stop the growth or spread of cancer by blocking the vascular endothelial growth factor

  • Change4Life warns of cancer risk from drinking 'a little too much'

    Updated: 2012-02-07 16:12:00
    People are at risk from serious illness including cancer, heart disease and stroke if they drink just slightly more than they should, Andrew Lansley has warned.

  • Promising breast cancer prevention drug 'weakens bones'

    Updated: 2012-02-07 13:41:00
    The drug exemestane, which is used to treat breast cancer and is also in trials to prevent the disease developing in postmenopausal women, significantly worsens age-related bone loss, according to a study from Canada.

  • Benefit of Bone Drug in Prostate Cancer in Doubt

    Updated: 2012-02-07 13:00:00
    WASHINGTON -- FDA reviewers have questioned whether expanding the indication for Amgen's denosumab (Xgeva) to prevent the spread of prostate cancer to the bones would provide much added benefit.

  • Video Interview Explaining That Provenge Actually Has A 7.8 Month Life Extension Advantage

    Updated: 2012-02-06 20:52:06
    As a follow up to my last post about the three posters that appeared at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium meeting I am going to share with you a video interview with Dr. Chadi Nabhan. Dr. Nabhan talks about his presentation about the phase III results of the Provenge IMPACT [...]

  • Abbreviated Radiotherapy Shows Promise in Prostate Ca

    Updated: 2012-02-05 17:13:54
    SAN FRANCISCO -- Dramatically condensing radiation treatment for early prostate cancer into just five fractions produces good results without much toxicity, an early-phase study suggested.

  • Vaccine Eyed for Early-Stage Prostate Ca

    Updated: 2012-02-04 23:03:35
    SAN FRANCISCO -- The immunotherapy agent sipuleucel-T (Provenge) appears safe for use earlier in prostate cancer, researchers found.

  • Bone Drug Slows Mets in Aggressive Prostate Ca

    Updated: 2012-02-04 22:57:55
    SAN FRANCISCO -- Denosumab (Xgeva) delays onset of bone metastases for even the highest-risk prostate cancer patients, researchers found.

  • Booze and Family History of Colon Cancer a Bad Mix Study

    Updated: 2012-02-03 23:14:08
    : Health News Booze and Family History of Colon Cancer a Bad Mix : Study Print E-mail FRIDAY , Feb . 3 HealthDay News People who consume a few alcoholic drinks a day and have a family history of colorectal cancer are at increased risk for developing colon cancer , new research . suggests For the study , researchers in Boston examined data from more than 87,000 women in the Nurses' Health Study and 47,000 men in the Health Professionals Follow-up Study , and found that 1,801 cases of colon cancer were diagnosed among the participants from 1980 . onward People with a family history of colorectal cancer who drank an average of 30 or more grams of alcohol per day about 2.5 typical drinks in the United States were at increased risk for colon cancer , according to lead author Eunyoung Cho , of

  • Sleep Troubles May Up Prostate Cancer Risk

    Updated: 2012-02-03 22:04:02
    SAN FRANCISCO -- Severe sleep problems suggestive of insomnia are associated with an increased risk of prostate cancer among older men, researchers found.

  • Metastatic Prostate Cancer Often Untreated

    Updated: 2012-02-03 21:09:14
    SAN FRANCISCO — Prostate cancer that has already spread to other organs at time of diagnosis is left untreated in 11% of cases, and demographics make a difference in the decision, researchers reported.

  • Dendreon Has Three Posters At ASCO That Add New And Great News For Men With Advanced Prostate Cancer

    Updated: 2012-02-03 16:29:49
    The American Society of Clinical Oncologists (ASCO) posted on Wednesday the abstracts from the Genitourinary Conference which is scheduled for February 2-4 in San Francisco, California. Dendreon, the creator of the immunotherapy Provenge for men with metastatic castrate resistant advanced prostate cancer has three very interesting and informative posters which will appear at the conference. [...]

  • Startling reduction in Heart Attack Deaths in Wartime Norway

    Updated: 2012-02-02 21:39:58
    This is a fascinating case study that brings relevant evidence pertinent to heart disease directly to the forefront. It should serve as a convincing argument about why people suffer from heart attacks, and also act as a guide on how to avoid them, which is the primary reason that the ‘Lower Blood Pressure’ website exists. [...]

  • Most Common Tx for Prostate Ca Not Best Value

    Updated: 2012-02-02 19:53:19
    SAN FRANCISCO -- External beam radiation is the most toxic and expensive among common prostate cancer treatments over the long-term, a national registry study suggested.

  • Proton Beam No Better than IMRT for Prostate Cancer

    Updated: 2012-02-02 18:48:22
    SAN FRANCISCO -- For localized prostate cancer, proton beam radiation offers no advantage in minimizing recurrences or side effects, study results suggested.

  • Announcing A Compassionate Use Trial of Alpharadin

    Updated: 2012-02-02 17:07:11
    Radium-223 choride, also known as Alpharadin, has demonstrated a small but statistically significant survival benefit in men with symptomatic metastatic castrate resistant prostate cancer (mCRPC). My expectation is that it will be approved by the FDA some time later this year. Additionally, my hope is that it will also be approved Europe. To read more [...]

  • Workouts Shape Up Genes, Prognosis in Prostate Ca

    Updated: 2012-02-02 04:38:08
    SAN FRANCISCO -- Regular vigorous exercise tones down tumor promoter genes and up regulates tumor suppressor genes for men with prostate cancer, researchers found.

  • Cancer Survivors Do Better With Exercise

    Updated: 2012-02-02 04:37:32
    Another large study has confirmed that cancer survivors have better physical function and quality of life when they are physically active after their treatment ends, researchers found.

  • Prostate cancer NICE decision 'makes no sense'

    Updated: 2012-02-02 00:01:00
    Cancer Research UK is urging a solution to the impasse over the advanced prostate cancer drug abiraterone, which has been turned down by NICE.

  • Prostate Cancer Bone Mets Target of New Agent

    Updated: 2012-02-01 18:49:34
    SAN FRANCISCO -- A novel drug that emits bone metastasis-targeted radiation cuts down on skeletal-related events in castration-resistant prostate cancer patients, researchers found.

  • Large study confirms benefits of exercise for some cancer patients

    Updated: 2012-02-01 15:46:00
    Physical activity, when appropriate, can improve patients' health and quality of life after they finish treatment, according to large analysis of over 30 studies of exercise and cancer, published in the BMJ.

  • Novel Androgen Drug Gets 'Wow' in Advanced Prostate Cancer

    Updated: 2012-02-01 12:30:00
    SAN FRANCISCO -- An investigational androgen receptor antagonist substantially boosts survival in castration-resistant prostate cancer, phase III trial results showed.

  • Research backs benefits of new bowel cancer test

    Updated: 2012-01-31 21:00:00
    A test being introduced by the Government is effective at detecting bowel cancer, a US study has confirmed.

  • REVLIMID FAILS TO EXTEND SURVIVAL IN ADVANCED PROSTATE CANCER

    Updated: 2012-01-31 17:01:35
    The late-stage trial of Revlimid (lenalidomide) for the treatment of advanced prostate cancer has been discontinued after preliminary data shows that it does not extend survival! The independent monitoring committee recommended that the pivotal Phase III Mainsail trial be halted after it determined that adding Revlimid to standard treatments would not significantly increase the overall [...]

  • Studies shine light on genetics of childhood brain tumours

    Updated: 2012-01-30 16:22:00
    New studies have found genes linked to two types of aggressive childhood brain tumour, and could aid the development of effective treatments.

  • Government launches bowel cancer campaign

    Updated: 2012-01-30 00:01:00
    The Government has today launched a new campaign to help people spot the warning signs of bowel cancer.

  • Gene test could identify early stage lung cancer patients who may benefit from extra chemo

    Updated: 2012-01-27 14:03:03
    Researchers in the US have developed a gene test that seems to be able to predict which early stage (stage I) non-small cell lung cancer patients have the poorest prognosis.

  • Cancer Research UK launches trial of new drug to treat acute childhood leukaemia

    Updated: 2012-01-27 00:01:00
    Cancer Research UK's Drug Development Office has opened the first trial of a new type of drug to treat children aged from six months to 18 years with acute leukaemia, who are no longer responding to treatment.

  • Oral HPV 'more common in men than women'

    Updated: 2012-01-26 19:02:00
    Research in the US has found that oral infection with the human papillomavirus (HPV) may be more common among men than women.

  • 50% Reduction in Heart Attack Instances in the United Kingdom

    Updated: 2012-01-26 08:37:04
    Here’s some great news about heart attacks and strokes for a change.   The British Heart Foundation has released new statistics in January 2012 that show a 50% reduction in the number of heart attacks suffered by people in the United Kingdom over the period from 2002 to 2012.   Furthermore, of those who do suffer [...]

  • CRT spins out company to develop cancer surgery machine to melt tumours

    Updated: 2012-01-26 00:01:00
    Cancer Research Technology, the commercial arm of Cancer Research UK, has today launched Acublate Limited, a spin-out company which will develop a next-generation High Intensity Focused Ultrasound (HIFU) surgery device to treat a range of solid tumour types.

  • Women with faulty BRCA genes more likely to survive ovarian cancer

    Updated: 2012-01-24 21:00:00
    Ovarian cancer patients who carry BRCA1 or BRCA2 mutations are significantly more likely to survive the disease than women without these faulty genes, according to research published in the Journal of the American Medical Association.

  • Drug could delay invasive treatment for low-risk prostate cancer

    Updated: 2012-01-24 00:01:00
    Dutasteride, a drug already used to treat men with enlarged prostates, can also slow the growth of early-stage prostate cancer that hasn't spread, according to research from Canada.

  • OncoGenex To Present OGX-427 Data At ASCO 2012 Genitourinary Cancers Symposium

    Updated: 2012-01-23 16:24:04
    Maybe we are about to have another new treatment for advanced prostate cancer that will earn the coveted descriptor, “ON THE HORIZON.” OncoGenex Pharmaceuticals Inc. (OGXI) has said that they will be presenting preliminary data from their phase 2 trials evaluating their investigational compound OGX-427, in prostate and bladder cancer. The data will be presented [...]

  • Scientists reveal first 3D image of cancer prevention molecule

    Updated: 2012-01-22 18:00:00
    Cancer Research UK scientists have created the first 3D structure of a key protein that protects against the development of cancer, according to research published in Nature Structural & Molecular Biology today.

  • Gene offers clue to cause of oesophageal cancer

    Updated: 2012-01-19 16:53:00
    Scientists have discovered the gene behind a rare skin condition that predisposes to oesophageal cancer, according to a study part-funded by Cancer Research UK.

  • Friends and family are encouraging youngsters to risk health for sunbed glow

    Updated: 2012-01-19 11:31:00
    As the post-Christmas January blues take hold, young people are risking damage to their health and appearance by using sunbeds on the recommendation of friends and family, according to a new survey by Cancer Research UK.

  • The Value of Evaluating Circulating Tumor Cells – Better Survival Predictions

    Updated: 2012-01-19 01:18:41
    The use of the PSA as a prostate cancer screening tool has been a controversial issue for many years. Within the last year the issue has again come to the forefront of the public awareness, especially because of the recent move of the U.S Preventative Task Force to discourage using the PSA as a screening [...]

  • Scientists uncover reason for second cancers after targeted melanoma treatment

    Updated: 2012-01-19 00:00:00
    An international study has uncovered how secondary skin cancers sometimes develop in malignant melanoma patients who are treated with an experimental drug.

  • 'Gatekeeper' cells could prevent cancer spread

    Updated: 2012-01-18 17:14:00
    Laboratory research in the US has discovered that a little-studied 'gatekeeper' cell may prevent cancer spreading around the body.

  • Researchers defend HRT breast cancer study

    Updated: 2012-01-17 16:44:00
    The authors of a study showing that hormone replacement therapy (HRT) increases the risk of breast cancer have defended their findings, following criticism from a team of experts linked to pharmaceutical companies that make the treatment.

  • Bavarian Nordic Initiates Pivotal Phase 3 Trial of PROSTVAC® Prostate Cancer Immunotherapy

    Updated: 2012-01-17 16:14:14
    Bavarian Nordic A/S (BAVA) announced on November 15, that its subsidiary, BN ImmunoTherapeutics has started the pivotal Phase 3 trial of PROSTVAC® for men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. The trial is being conducted under a Special Protocol Assessment agreement with the FDA. Notice this trial has the same criteria as [...]

  • Fluorescent dye pinpoints tiniest signs of oesophageal cancer

    Updated: 2012-01-15 18:00:00
    A fluorescent dye that can be sprayed onto the oesophagus - the food pipe - could be used to detect oesophageal cancer earlier and spare patients unnecessary treatment, according to research published today in Nature Medicine.

  • Estrogen May Play Role in Melanoma Recurrence- A Warning for Those of Us Who Are Considering Estrogen as a Second Line ADT

    Updated: 2012-01-14 17:53:11
    According to a an article published in the January 2012 issue of Cancer Prevention Research, estrogen may play a role in Melanoma recurrences! The article described a large cohort study of women who were put on an anti-estrogen therapy. The study concluded that those women on the anti-estrogen therapy had a lower risk of melanoma. [...]

  • Get the Facts: HPV

    Updated: 2012-01-13 22:24:00
    : About Us Sponsored : by CTCA Cancer News Avastin May Help Some With Ovarian Cancer : Studies Survival without disease getting worse rose slightly , but benefit on overall survival remains unclear Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer

  • Processed meat may increase pancreatic cancer risk

    Updated: 2012-01-13 00:01:00
    Eating too much processed meat may increases the risk of pancreatic cancer, new research published in the British Journal of Cancer finds today.

Previous Months Items

Jan 2012 | Dec 2011 | Nov 2011 | Oct 2011 | Sep 2011 | Aug 2011